Skip to Content

CD33, FLOWCYTOMETRY (SDL10809)

https://www.scanlabglobal.com/web/image/product.template/4366/image_1920?unique=18393fc
This test measures CD33 expression to diagnose AML. Positive results guide gemtuzumab ozogamicin therapy, targeting CD33-positive myeloid cells in acute myeloid leukemia treatment.

300.00 AED 300.0 AED 300.00 AED

300.00 AED

Not Available For Sale

This combination does not exist.